These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 31887477)
1. Design, synthesis and bioactivity evaluation of coumarin-chalcone hybrids as potential anticancer agents. Wang Y; Zhang W; Dong J; Gao J Bioorg Chem; 2020 Jan; 95():103530. PubMed ID: 31887477 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of xanthohumol analogues and discovery of potent thioredoxin reductase inhibitor as potential anticancer agent. Zhang B; Duan D; Ge C; Yao J; Liu Y; Li X; Fang J J Med Chem; 2015 Feb; 58(4):1795-805. PubMed ID: 25629304 [TBL] [Abstract][Full Text] [Related]
3. Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for anti-proliferative activity. Ng HL; Chen S; Chew EH; Chui WK Eur J Med Chem; 2016 Jun; 115():63-74. PubMed ID: 26994844 [TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of benzylidenecyclohexenones as TrxR inhibitors displaying high anticancer activity and inducing ROS, apoptosis, and autophagy. Qian J; Xu Z; Meng C; Liu J; Hsu PL; Li Y; Zhu W; Yang Y; Morris-Natschke SL; Lee KH; Zhang Y; Ling Y Eur J Med Chem; 2020 Oct; 204():112610. PubMed ID: 32736231 [TBL] [Abstract][Full Text] [Related]
5. Novel Phenylmethylenecyclohexenone Derivatives as Potent TrxR Inhibitors Display High Antiproliferative Activity and Induce ROS, Apoptosis, and DNA Damage. Wang X; Qian J; Zhu P; Hua R; Liu J; Hang J; Meng C; Shan W; Miao J; Ling Y ChemMedChem; 2021 Feb; 16(4):702-712. PubMed ID: 33085980 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological evaluation of a novel indoleamine 2,3-dioxigenase 1 (IDO1) and thioredoxin reductase (TrxR) dual inhibitor. Fan QZ; Zhou J; Zhu YB; He LJ; Miao DD; Zhang SP; Liu XP; Zhang C Bioorg Chem; 2020 Dec; 105():104401. PubMed ID: 33113415 [TBL] [Abstract][Full Text] [Related]
7. Discovery of novel chalcone-dithiocarbamates as ROS-mediated apoptosis inducers by inhibiting catalase. Fu DJ; Li JH; Yang JJ; Li P; Zhang YB; Liu S; Li ZR; Zhang SY Bioorg Chem; 2019 May; 86():375-385. PubMed ID: 30763884 [TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of new coumarin hybrids and insight into their mode of antiproliferative action. Elshemy HAH; Zaki MA Bioorg Med Chem; 2017 Feb; 25(3):1066-1075. PubMed ID: 28038941 [TBL] [Abstract][Full Text] [Related]
9. Discovery of New Monocarbonyl Ligustrazine-Curcumin Hybrids for Intervention of Drug-Sensitive and Drug-Resistant Lung Cancer. Ai Y; Zhu B; Ren C; Kang F; Li J; Huang Z; Lai Y; Peng S; Ding K; Tian J; Zhang Y J Med Chem; 2016 Mar; 59(5):1747-60. PubMed ID: 26891099 [TBL] [Abstract][Full Text] [Related]
10. Ruthenium(II) salicylate complexes inducing ROS-mediated apoptosis by targeting thioredoxin reductase. Chen JC; Zhang Y; Jie XM; She J; Dongye GZ; Zhong Y; Deng YY; Wang J; Guo BY; Chen LM J Inorg Biochem; 2019 Apr; 193():112-123. PubMed ID: 30711557 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of novel methylenecyclohexenone derivatives as TrxR inhibitors in suppressing the proliferation and metastasis of human cancer cells. Meng C; Qian J; Xu Z; Liu J; Shan W; Zhu P; Zhu W; Miao J; Ling CC; Ling Y Bioorg Chem; 2020 Dec; 105():104360. PubMed ID: 33074118 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of curcumin analogues as potential thioredoxin reductase inhibitors. Qiu X; Liu Z; Shao WY; Liu X; Jing DP; Yu YJ; An LK; Huang SL; Bu XZ; Huang ZS; Gu LQ Bioorg Med Chem; 2008 Sep; 16(17):8035-41. PubMed ID: 18678491 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and evaluation of chalcone analogues incorporate α,β-Unsaturated ketone functionality as anti-lung cancer agents via evoking ROS to induce pyroptosis. Zhu M; Wang J; Xie J; Chen L; Wei X; Jiang X; Bao M; Qiu Y; Chen Q; Li W; Jiang C; Zhou X; Jiang L; Qiu P; Wu J Eur J Med Chem; 2018 Sep; 157():1395-1405. PubMed ID: 30196062 [TBL] [Abstract][Full Text] [Related]
14. Current Progresses in Metal-based Anticancer Complexes as Mammalian TrxR Inhibitors. Cheng Y; Qi Y Anticancer Agents Med Chem; 2017; 17(8):1046-1069. PubMed ID: 28270080 [TBL] [Abstract][Full Text] [Related]
15. EGFR inhibitors and apoptotic inducers: Design, synthesis, anticancer activity and docking studies of novel xanthine derivatives carrying chalcone moiety as hybrid molecules. Abou-Zied HA; Youssif BGM; Mohamed MFA; Hayallah AM; Abdel-Aziz M Bioorg Chem; 2019 Aug; 89():102997. PubMed ID: 31136902 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, cytotoxicity and mechanism of novel dihydroartemisinin-coumarin hybrids as potential anti-cancer agents. Yu H; Hou Z; Tian Y; Mou Y; Guo C Eur J Med Chem; 2018 May; 151():434-449. PubMed ID: 29649740 [TBL] [Abstract][Full Text] [Related]
17. Small Molecules to Target the Selenoprotein Thioredoxin Reductase. Zhang B; Liu Y; Li X; Xu J; Fang J Chem Asian J; 2018 Dec; 13(23):3593-3600. PubMed ID: 30204305 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of (2E)-(2-oxo-1, 2-dihydro-3H-indol-3-ylidene)acetate derivatives as anti-proliferative agents through ROS-induced cell apoptosis. Song Z; Chen CP; Liu J; Wen X; Sun H; Yuan H Eur J Med Chem; 2016 Nov; 124():809-819. PubMed ID: 27643639 [TBL] [Abstract][Full Text] [Related]
19. Biological evaluation of indolizine-chalcone hybrids as new anticancer agents. Park S; Kim EH; Kim J; Kim SH; Kim I Eur J Med Chem; 2018 Jan; 144():435-443. PubMed ID: 29288944 [TBL] [Abstract][Full Text] [Related]
20. Novel 1-(7-ethoxy-1-benzofuran-2-yl) substituted chalcone derivatives: Synthesis, characterization and anticancer activity. Coskun D; Erkisa M; Ulukaya E; Coskun MF; Ari F Eur J Med Chem; 2017 Aug; 136():212-222. PubMed ID: 28494257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]